Related Image: Novel publishing approach puts textbook in more hands |
(Date:12/3/2009)... N.Y., Dec. 3 Nikon Corporation, an innovator ... has signed a licensing agreement with Harvard University ... Optical Reconstruction Microscopy (STORM) technology. Under the terms ... microscopy systems and market them with the N-STORM ...
(Date:12/3/2009)... Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: ... take charge of their health at home through the merger ... of $3.00 per share on its Series B Convertible Perpetual ... shares of Series B stock in an amount per share ...
(Date:12/2/2009)... 2 Reportlinker.com announces that a new ... catalogue: ,, Neurostimulation - A Global ... ,, The world neurostimulation market stands ... population, and the resultant rise in age-related ...
(Date:12/2/2009)... Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today ... and dosimetry trial of Cotara® in patients with relapsed ... Cotara is a targeted monoclonal antibody linked to ... for GBM. Cotara specifically targets cells at the ...
Breaking Biology Technology:Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5... CLAREMONT, Calif., Oct. 2 Kiwa,Bio-Tech Products Group Corporation ... Feed Limited Liability Company, located in,Wuqing District in Tianjin, ... September. Mr. Wei Li, Chairman and CEO of ... of Kiwa,s bio-feed products to approximately 7,550 tons,during the ...
... Choice in All Lines ... Decision Resources, WALTHAM, Mass., Oct. 2 ... advisory firms focusing on pharmaceutical and,healthcare issues, finds ... doctor specialty. According to the new report entitled,Treatment ...
... 2 GeneGo, Inc., the leading,systems biology tools company, ... of Akzo Nobel, have extended their GeneGo,software and database ... also added MetaLink so that they can upload their ... MetaCore,s manually,curated content. GeneGo offers easy to use ...
Other Biology Technology:Kiwa Bio-Tech Ships 2,700 Tons of Bio-feed in One Month 2Patient Treatment for Bipolar Disorder Varies Depending on Doctor Specialty; Well Designed Clinical Trials May Be The Answer 2Patient Treatment for Bipolar Disorder Varies Depending on Doctor Specialty; Well Designed Clinical Trials May Be The Answer 3Organon Extends MetaCore License and Adds MetaLink 2Ready-to-use solution....
...
... Polyclonal Antibody Production Conjugated peptides ... ten-week protocol to produce antibodies in 2 ... ml antiserum) ELISA test until the titer ... reaches target titer Protein G purification ...
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: